What to Know About Lung Cancer That Has Spread to the Brain

Brain Metastasis
The specific location of these tumor cells in the brain determines which symptoms a person will likely experience, and it may also impact their treatment options.
Signs and Symptoms of Lung Cancer Metastasis in the Brain
As metastatic tumors in the brain grow, they can directly damage cells or affect the brain indirectly by compressing parts of it or causing swelling and increased pressure within the skull. Early warning signs can be subtle and may be attributed to other causes, including chemotherapy, says Jonathan Goldman, MD, a clinical instructor of hematology and oncology at UCLA Health Jonsson Comprehensive Cancer Center in Los Angeles.

- Headaches
- Fatigue
- Nausea or vomiting
- Seizures
- Blurred vision
- Balance problems
- Loss of sensation or weakness along one side of the body
- Difficulty walking
- Loss of coordination (such as reaching for a door handle and missing)
- Speech problems
- Cognitive problems or memory loss
- Personality or behavior changes
Diagnosing Brain Metastasis
Treatment Options for Lung Cancer With Brain Metastasis
Surgery
Radiation
Radiation therapy uses X-rays or other high-energy beams to kill cancer cells. Different methods of radiation are used to treat brain metastases.
Systemic Therapy
With systemic therapies, such as chemotherapy, immunotherapy, and targeted therapy, drugs travel through the bloodstream to reach cancer cells throughout the body.
Targeted therapies can identify and attack specific cancer cells with minimal harm to normal cells. For people with lung cancer cells that have specific mutations (such as EGFR and ALK), these therapies can be highly effective.
But if your lung cancer doesn’t carry these specific mutations or has spread elsewhere in the body, your doctor may consider other systemic therapies, such as immunotherapy (which uses medicine to activate your own immune system to recognize and kill cancer cells) or chemotherapy.
Palliative Care
Palliative care can help mitigate the side effects of both the cancer and its treatment and significantly improve quality of life.
Prognosis and Outlook
Clinical trials are regularly being conducted to find ways to improve treatment for people with lung cancer that’s metastasized to the brain. Ask your doctor whether you may be a candidate for such a trial. You can also search for a clinical trial in your area at ClinicalTrials.gov.
“Brain metastasis has traditionally been an area that was difficult to study,” Goldman says. “But, thankfully, more and more studies are focused on exactly this problem.”
The Takeaway
- Lung cancer that has metastasized to the brain is rarely curable, but there are many treatment options that can slow cancer growth and provide symptom relief.
- Imaging tests, biopsies, and blood tests for tumor markers are used in the diagnosis process, and they may continue to be used afterward to monitor cancer progression.
- Surgery, chemotherapy, radiation, and targeted therapies are common treatments for brain metastases.
- New technologies and treatments are improving the outlook for people with brain metastases.
Resources We Trust
- Cleveland Clinic: Brain Metastases
- National Brain Tumor Society: Metastatic Brain Tumors
- LUNGevity: Transforming Lung Cancer
- Mayo Clinic: Brain Metastases
- American Lung Association: Lung Cancer
Additional reporting by Erica Patino.
- Brain Metastasis From Lung Cancer. American Lung Association. October 1, 2024.
- Wang S et al. Lung Cancer With Brain Metastasis — Treatment Strategies and Molecular Characteristics. Journal of Clinical Medicine. December 3, 2024.
- Brain Metastases. Cleveland Clinic. April 16, 2024.
- Brain Metastases: Symptoms and Causes. Mayo Clinic. November 20, 2024.
- Metastatic Brain Tumors. Cleveland Clinic.
- Brain Metastases: Diagnosis and Treatment. Mayo Clinic. November 20, 2024.
- PET Scan. Cleveland Clinic. October 19, 2022.
- CT (Computed Tomography) Scan. Cleveland Clinic. June 13, 2023.
- Nelson TA et al. Targeting Lung Cancer Brain Metastases: A Narrative Review of Emerging Insights for Anaplastic Lymphoma Kinase (ALK)-Positive Disease. Translational Lung Cancer Research. February 3, 2023.
- What Is Stereotactic Radiosurgery? Memorial Sloan Kettering Cancer Center.
- Myall NJ et al. Management of Brain Metastases in Lung Cancer: Evolving Roles for Radiation and Systemic Treatment in the Era of Targeted and Immune Therapies. Neuro-Oncology Advances. November 27, 2021.
- Supportive Care. Memorial Sloan Kettering Cancer Center.

Conor Steuer, MD
Medical Reviewer
Conor E. Steuer, MD, is medical oncologist specializing in the care of aerodigestive cancers, mesothelioma, and thymic malignancies and an assistant professor in the department of hematology and medical oncology at the Emory University School of Medicine in Atlanta. He joined the clinical staff at Emory's Winship Cancer Institute as a practicing physician in July 2015. He currently serves as chair of the Lung and Aerodigestive Malignancies Working Group and is a member of the Discovery and Developmental Therapeutics Research Program at Winship.
Dr. Steuer received his medical degree from the New York University School of Medicine in 2009. He completed his postdoctoral training as a fellow in the department of hematology and medical oncology at the Emory University School of Medicine, where he was chief fellow in his final year.
He has been active in research including in clinical trial development, database analyses, and investigation of molecular biomarkers. He is interested in investigating the molecular biology and genomics of thoracic and head and neck tumors in order to be able to further the care of these patient populations. Additionally, he has taken an interest in utilizing national databases to perform clinical outcomes research, as well as further investigate rare forms of thoracic cancers.
Steuer's work has been published in many leading journals, such as Cancer, the Journal of Thoracic Oncology, and Lung Cancer, and has been presented at multiple international conferences.

Julia Califano
Author
Julia Califano is an award-winning health journalist with a passion for turning complex medical research and information into news you can actually use and understand. She strives to help people feel more in control of their lives, conditions, and overall health.
In addition to Everyday Health, Julia's work has been featured in SELF, Good Housekeeping, Women’s Health, Health, DailyWorth, More, Food & Wine, Harper's Bazaar, the Slingshot Fund, Glamour, and Time Inc. Content Solutions, to name a few. She has also served as an editor and writer at Condé Nast, Hearst, and Time Inc.
Outside of work, Julia's favorite things include photography, summers on Cape Cod, good coffee, hiking, and (when her kids allow it) reading. She lives in the New York City area with her husband and two sons.